Before You Compare PBMs, HR and Finance Need the Same Scorecard

Two teams can evaluate the same PBM proposal and reach different conclusions. Agreeing on the decision rules first can lead to a better business decision.

  • 4 Min read

  • November 19, 2026

Lankford Wade

Lankford Wade

President and Chief Financial Officer
Best Practices

Finance sees a PBM proposal with stronger financial guarantees and a lower projected cost.

HR sees higher member costs, a more difficult implementation, and potential disruption.

Both teams may be reading the proposal correctly.

They are simply measuring success differently.

That is why the most important HR and Finance work should happen before the PBM proposals arrive.

The teams need to agree on what the organization is trying to improve, which tradeoffs it is willing to make, and how it will judge the result.

The financial pressure makes that discipline more important.

Private-sector health-benefit costs rose 6.4% over the 12 months ending September 2026, compared with 3.1% growth in wages and salaries.¹ Aon projects U.S. employer healthcare costs will increase 9.5% in 2027 before employers take action to reduce the increase.²

Every additional healthcare dollar competes with another possible investment, including wages, hiring, retirement benefits, technology, and growth.

Start with the problem, not the PBM

Before comparing vendors, leadership should be able to answer a simpler question:

What are we trying to improve?

The answer may be rising pharmacy trend. Specialty volatility. Member affordability. Access to treatment. A contract that limits the employer’s choices. Poor reporting. An operating model that creates too much work for HR.

Different problems require different solutions.

This matters because employers are actively reconsidering how pharmacy benefits are purchased. Mercer reports that 41% of large employers are evaluating different contracting models from major PBMs, while 37% are evaluating new and emerging PBMs.³

Brokers and consultants can help employers understand the available models and evaluate the options. But they should be working from the same priorities HR and Finance have agreed on. Otherwise, a strong proposal on paper may not address the problem the organization actually needs to solve.

A market review works best when everyone is clear on what the next model needs to fix.

Build the scorecard before reviewing the bids

HR and Finance do not need to evaluate every issue in the same way.

They do need one aligned scorecard.

From a financial perspective, the question is not simply which proposal projects the lowest cost. It is which one offers the best value when cost, risk, employee impact, and the ability to deliver are considered together.

I believe that scorecard should cover six areas.

Plan economics. What is the plan ultimately expected to pay? What assumptions drive the forecast? Which fees and guarantees matter? What could make the estimate wrong?

Member impact. What will employees pay through copays, coinsurance, deductibles, or other cost-sharing? Where could affordability become a barrier? How many patients will have their existing therapies impacted by any changes?

Risk. Where is specialty exposure concentrated? What financial risk stays with the employer? How do stop-loss terms, high-cost claims, or utilization changes affect the forecast?

Access and clinical fit. Can members receive clinically appropriate therapy without avoidable delay? Does the employer have meaningful choice over formulary, clinical, and pharmacy decisions?

Implementation. Can the PBM deliver a reliable transition? How will the organization confirm claims and pricing accuracy, protect members who are in treatment, and resolve issues quickly? What work will fall on HR, Finance, IT, and the benefits team?

Measurement and control. What will count as success? Can the employer verify actual costs, fees, savings, and performance against the original proposal? What decisions can it change later, and who is accountable when results fall short?

Decide which tradeoffs are acceptable

There may not be one option that wins every category.

A model with lower projected plan cost could increase member cost.

A richer benefit may improve access while increasing utilization risk.

A model with stronger guarantees may provide predictability while giving the employer less flexibility.

A transition may create better long-term value, but leadership needs to weigh the potential benefits against implementation costs, patient disruption risk, and the effort needed to make the change work.

Those are business tradeoffs.

HR should understand the economics well enough to evaluate them.

Finance should understand the workforce impact well enough to evaluate them.

Leadership then has one decision to make with both in view.

Define the result before implementation

The same scorecard used to choose the PBM should help evaluate it later.

If reducing specialty cost was a priority, define the baseline and the measure.

If member affordability mattered, track what employees actually paid.

If easier access was part of the decision, measure whether delays and barriers were resolved.

If financial predictability mattered, compare actual results with the assumptions used to make the decision.

The goal is not to create the longest scorecard.

It is to make sure the organization measures what it said mattered.

Make one business decision

HR should not carry the people risk alone.

Finance should not evaluate pharmacy only through projected savings.

The strongest PBM decision happens when both teams agree on the problem, the tradeoffs, and the measures before they compare the vendors.

Then the question becomes more useful than “Which PBM has the best offer?”

It becomes:

Which model makes the most sense for our organization across cost, risk, access, employee impact, and control?

That is how a PBM decision becomes a business decision rather than another renewal exercise.

Our PBM Decision Checklist can help HR and Finance work through the practical questions around economics, member disruption, formulary changes, implementation, and governance.

Sources

¹ U.S. Bureau of Labor Statistics. “Employment Cost Index”, September 2026, released October 30.
https://www.bls.gov/news.release/eci.nr0.htm

² Aon. “Healthcare Cost Increases Show No Signs of Slowing: What Employers Can Do.” July 17, 2026.
https://www.aon.com/en/insights/articles/healthcare-cost-increases-show-no-signs-of-slowing-what-employers-can-do

³ Mercer. “Employers Are Shifting Health Care Costs to Employees but Also Leveraging New Approaches to Minimize Impact.” June 11, 2026.
https://www.mercer.com/en-us/about/newsroom/employers-are-shifting-healthcare-costs-to-employees/

Download the PBM Reform Readiness Checklist

Download the GLP-1 Planning Checklist